Latest News about SLDB
Recent news which mentions SLDB
7 Sizzling Stocks That Are Oblivious to the Manic Market
October 20, 2022
From InvestorPlace
Solid Biosciences Touts Encouraging Preclinical Data From Potential Duchenne Gene Therapy
October 17, 2022
Tickers
SLDB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
From Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
September 30, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 30, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 22, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 21, 2022
From Benzinga
Solid Biosciences Earnings Perspective: Return On Capital Employed
September 06, 2022
Tickers
SLDB
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 19, 2022
From Benzinga
Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry?
August 09, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
April 28, 2022
From Benzinga
61 Biggest Movers From Yesterday
April 28, 2022
From Benzinga
From Benzinga
Earnings Scheduled For April 27, 2022
April 27, 2022
From Benzinga
From InvestorPlace
23 Stocks Moving in Thursday's Pre-Market Session
March 31, 2022
From Benzinga
96 Biggest Movers From Yesterday
March 15, 2022
From Benzinga
Solid Biosciences Posts Two-Year Efficacy, Safety Data From Duchenne Gene Therapy Trial
March 14, 2022
Tickers
SLDB
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
March 14, 2022
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Free News Feed
Get our RSS Feed!
© Copyright 2008 StreetInsider.com
Custom Website Design by Active Media Architects
Custom Website Design by Active Media Architects
